Epigenetic modulation of the retinoid X receptor α by green tea in the azoxymethane-ApcMin/+ mouse model of intestinal cancer

Molecular Carcinogenesis

Volumn 48, Issue 10, 2009, Pages 920-933

  Volate, Suresh R ^a   Muga, Stephanie J ^b   Issa, Ala Y ^a   Nitcheva, Daniela ^c   Smith, Theresa ^c   Wargovich, Michael J ^d  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA AIKEN   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

catenin; ApcMin + mouse model; Azoxymethane (AOM); Colon cancer; Cyclin D1; Green tea; Methylation; RXR

Indexed keywords

AZOXYMETHANE; BISULFITE; CAFFEINE; CYCLIN D1; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLIC ACID; MESSENGER RNA; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR; BETA CATENIN; CARCINOGEN; RETINOID X RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEA; ADENOMA; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOWN REGULATION; ENZYME IMMUNOASSAY; GENETIC EPIGENESIS; GENETICS; INTESTINE TUMOR; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

MUS;

ADENOMA; ANIMALS; AZOXYMETHANE; BETA CATENIN; CAMELLIA SINENSIS; CARCINOGENS; CYCLIN D1; DISEASE MODELS, ANIMAL; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; FEMALE; GENES, APC; IMMUNOENZYME TECHNIQUES; INTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; RETINOID X RECEPTOR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEA;

EID: 70349975929     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20542     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Koo MW, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol 2004; 177-185.
3. Jung YD, Kim MS, Shin BA, et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 2001; 844-850.
4. Raederstorff DG, Schlachter MF, Elste V, Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 2003; 326-332. (Pubitemid 36836237)
5. Yang CS. Inhibition of carcinogenesis by tea. Nature 1997; 134-135.
6. Arab L, Il'yasova D. The epidemiology of tea consumption and colorectal cancer incidence. J Nutr 2003; 3310S-3318S.
7. Tedeschi E, Suzuki H, Menegazzi M. Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition. Ann N Y Acad Sci 2002; 435-437. (Pubitemid 36125048)
8. Chung JY, Park JO, Phyu H, Dong Z, Yang CS. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3- gallate and theaflavin-3,3′-digallate. FASEB J 2001; 2022-2024.
9. Park AM, Dong Z. Signal transduction pathways: Targets for green and black tea polyphenols. J Biochem Mol Biol 2003;66-77. (Pubitemid 36836258)
10. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002; 25-54.
11. Lotan R. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Anticancer Res 1996; 2415-2419. (Pubitemid 26325424)
12. Morriss-Kay GM, Ward SJ. Retinoids and mammalian development. Int Rev Cytol 1999; 73-131.
13. De Luca LM. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 1991; 2924-2933.
14. Okuno M, Kojima S, Matsushima-Nishiwaki R, et al. Retinoids in cancer chemoprevention. Curr Cancer Drug Targets 2004; 285-298.
15. Berrodin TJ, Marks MS, Ozato K, Linney E, Lazar MA. Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein. Mol Endocrinol 1992; 1468-1478.
16. Farias EF, Arapshian A, Bleiweiss IJ, WaxmanS, Zelent A, Mira YL. Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ 2002; 335-341. (Pubitemid 34941066)
17. Wang Y, Fang MZ, Liao J, et al. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma. Clin Cancer Res 2003; 5257-5263. (Pubitemid 37413577)
18. Li LC, Dahiya R. MethPrimer: Designing primers for methylation PCRs. Bioinformatics 2002; 1427-1431. (Pubitemid 35414532)
19. Tanaka T, Dancheck BL, Trifiletti LC, et al. Altered localization of retinoid X receptor alpha coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells. Mol Cell Biol 2004; 3972-3982.
20. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003; 1-24. (Pubitemid 36627817)
21. Kikuchi A, Kishida S, Yamamoto H. Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 2006; 1-10. (Pubitemid 43352428)
22. Xiao JH, Ghosn C, Hinchman C, et al. Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. J Biol Chem 2003; 29954-29962.
23. Easwaran V, Pishvaian M, Salimuddin, Byers S. Crossregulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr Biol 1999; 1415-1418.
24. Bugge TH, Pohl J, Lonnoy O, Stunnenberg HG. RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J 1992; 1409-1418.
25. Froeschle A, Carnac G, Alric S, et al. RXR alpha is essential for mediating the all-trans retinoic acid-induced growth arrest of C2 myogenic cells. Oncogene 1996; 411-421.
26. Dahiya R, Park HD, Cusick J, Vessella RL, Fournier G, Narayan P. Inhibition of tumorigenic potential and prostate-specific antigen expression in LNCaP human prostate cancer cell line by 13-cis-retinoic acid. Int J Cancer 1994; 126-132. (Pubitemid 24310958)
27. Wu S, Zhang D, Zhang ZP, Soprano DR, Soprano KJ. Critical role of both retinoid nuclear receptors and retinoid-Xreceptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid. Oncogene 1998; 2839-2849. (Pubitemid 29010054)
28. Agarwal C, Chandraratna RA, Teng M, Nagpal S, Rorke EA, Eckert RL. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids. Cell Growth Differ 1996; 521-530. (Pubitemid 26362096)
29. Shao Z, Shen Z, Fontana JA. Expression of the retinoic acid nuclear receptors and retinoid X receptor gene in human breast cancer. Zhonghua Zhong Liu Za Zhi 1995; 425-428.
30. Nishizawa H,Manabe N, Morita M, Sugimoto M, Imanishi S, Miyamoto H. Effects of in utero exposure to bisphenol A on expression of RARalpha and RXRalpha mRNAs in murine embryos. J Reprod Dev 2003; 539-545.
31. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 2003; 146-150. (Pubitemid 36828724)
32. Dupont JM, Tost J, Jammes H, Gut IG. De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem 2004; 119-127.
33. Tost J, Dunker J, Gut IG. Analysis and quantification of multiple methylation variable positions in CpG islands by pyrosequencing. Biotechniques 2003; 152-156. (Pubitemid 36828725)
34. Yang CS, Prabhu S, Landau J. Prevention of carcinogenesis by tea polyphenols. Drug Metab Rev 2001; 237-253.
35. Byers S, Pishvaian M, Crockett C, et al. Retinoids increase cell-cell adhesion strength, beta-catenin protein stability, and localization to the cell membrane in a breast cancer cell line: A role for serine kinase activity. Endocrinology 1996; 3265-3273. (Pubitemid 26250173)
36. Schmitt-Graff A, Ertelt V, Allgaier HP, et al. Cellular retinolbinding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival. Hepatology 2003; 470-480.
37. Buentig N, Stoerkel S, Richter E, Dallmann I, Reitz M, Atzpodien J. Predictive impact of retinoid X receptor-alphaexpression in renal-cell carcinoma. Cancer Biother Radiopharm 2004; 331-342. (Pubitemid 38924497)
38. Li R, Saito T, Tanaka R, et al. Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium. Cancer Lett 2005; 33-40. (Pubitemid 40203168)
39. Fang MZ, Wang Y, Ai N, et al. Tea polyphenol (-)- epigallocatechin-3- gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003; 7563-7570.
40. Lee WJ, Shim JY, Zhu BT. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 2005; 1018-1030.